Development and evaluation of a community-based buprenorphine treatment intervention
Abstract Background The majority of Americans with opioid use disorder remain out of treatment. Operating in 33 states, Washington DC, and Puerto Rico, harm reduction agencies, which provide sterile syringes and other health services to people who inject drugs, are a key venue to reach out-of-treatm...
Saved in:
Main Authors: | Aaron D. Fox (Author), Nancy L. Sohler (Author), Taeko Frost (Author), Carolina Lopez (Author), Chinazo O. Cunningham (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
by: Travis M. Scott, et al.
Published: (2017) -
Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation
by: Andrea Jakubowski, et al.
Published: (2022) -
Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
by: Hiroko Furo, et al.
Published: (2021) -
Development and Implementation of Tennessee Nonresidential Buprenorphine Treatment Guidelines
by: Erica Schlesinger, et al.
Published: (2018) -
Factors in rural community buprenorphine dispensing
by: Erin G. Major, et al.
Published: (2023)